Impact and clinical significance of recurrent venous thromboembolism www.bjs.co.uk

British Journal of Surgery

Volumn 97, Issue 7, 2010, Pages 989-999

  Labropoulos, N ^a   Spentzouris, G ^a   Gasparis, A P ^a   Meissner, M ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

DIAGNOSTIC IMAGING; HUMAN; LUNG EMBOLISM; METABOLISM; PARADOXICAL EMBOLISM; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; RECURRENT DISEASE; REVIEW; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DIAGNOSTIC IMAGING; EMBOLISM, PARADOXICAL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MEDICATION ADHERENCE; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 77953629325     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7156     Document Type: Review

References (76)

1. Naess LA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-699. (Pubitemid 46563566)
2. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107(Suppl 1): 14-18.
3. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica 2007; 92: 199-205.
4. Labropoulos N, Jen J, Jen H, Gasparis AP, Tassiopoulos AK. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg 2010; 251: 749-753.
5. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7. (Pubitemid 126505333)
6. Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm 2007; 13: 475-486. (Pubitemid 350193368)
7. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780-1789. (Pubitemid 44631361)
8. Bruinstroop E, Klok FA, Van De Ree MA, Oosterwijk FL, Huisman MV. Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis. J Thromb Haemost 2009; 7: 611-618.
9. Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008; 149:481-490.
10. Prandoni P, Lensing AW, Bernardi. E, Villalta S, Bagatella P, Girolami A. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 2002; 88: 402-406. (Pubitemid 35021596)
11. Linkins LA, Pasquale P, Paterson S, Kearon C. Change in thrombus length on venous ultrasound, and recurrent deep vein thrombosis. Arch Intern Med 2004; 164: 1793-1796. (Pubitemid 39215650)
12. Fink AM, Mayer W, Steiner A. Extent of thrombus evaluated, in patients with recurrent and first deep vein thrombosis. J Vasc Surg 2002; 36: 357-360. (Pubitemid 35014972)
13. Rosen CL, Tracy JA. The diagnosis of lower extremity deep venous thrombosis. Emerg Med Clin North Am 2001; 19: 895-912. (Pubitemid 33116276)
14. Sampson FC, Goodacre SW, Thomas SM, van Beek FJ. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol 2007; 17: 175-181.
15. Carpenter JP, Holland GA, Baum RA, Owen RS, Carpenter JT, Cope C. Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg 1993; 18: 734-741. (Pubitemid 23346894)
16. Froehlich JB, Prince MR, Greenfield LJ, Downing LJ, Shah NL, Wakefield TW. 'Bull's-eye' sign on gadolinium-enhanced magnetic resonance venography determines thrombus presence and age: a preliminary study. J Vasc Surg 1997; 26: 809-816.
17. Spritzer CE, Trotter P, Sostman HD. Deep venous thrombosis: gradient-recalled-echo MR imaging changes over time - experience in 10 patients. Radiology 1998; 208: 631-639. (Pubitemid 28405096)
18. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006;354:2317-2327.
19. Goodman LR, Stein PD, Matta F, Sostman HD, Wakefield TW, Woodard PK et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am J Roentgenol 2007; 189: 1071-1076. (Pubitemid 350032993)
20. Park EA, Lee W, Lee MW, Choi SI, Jae HJ, Chung JW et al. Chronic-stage deep vein thrombosis of the lower extremities: indirect CT venographic findings. J Comput Assist Tomogr 2007; 31:649-656. (Pubitemid 47457686)
21. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759.
22. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-1472.
23. Clemens S, Leeper KV Jr. Newer modalities for detection of pulmonary emboli. Am J Med 2007; 120(Suppl 2): S2-S12. (Pubitemid 47488195)
24. Stein PD, Henry JW, Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreter agreement to the order of the involved pulmonary arterial branch. Radiology 1999; 210: 689-691. (Pubitemid 29124028)
25. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
26. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113:2011-2020.
27. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 2009;40:2349-2355.
28. Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P et al. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 2005; 3: 718-723. (Pubitemid 41647886)
29. Roumen-Klappe EM, den Heijer M, Janssen MC, van der Vleuten C, Thien T, Wollersheim H. The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study. Thromb Haemost 2005; 94: 825-830. (Pubitemid 41489245)
30. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004; 164:17-26. (Pubitemid 38067385)
31. Labropoulos N, Waggoner T, Sammis W, Samali S, Pappas PJ. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg 2008; 48: 407-412.
32. Prandoni P, Frulla M, Sartor D, Concolato A, Girolami A. Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost 2005; 3: 401-402.
33. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707.
34. Labropoulos N, Gasparis AP, Tassiopoulos AK. Prospective evaluation of the clinical deterioration in post-thrombotic limbs. J Vasc Surg 2009; 50: 826-830.
35. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med 1995; 155: 1031-1037.
36. Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32: 130-137. (Pubitemid 30461161)
37. Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009; 7: 1268-1275.
38. Baekgaard N, Broholm R, Just S, Jørgensen M, Jensen LP. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J VascEndovasc Surg 2010; 39: 112-117.\
39. Comerota AJ. The ATTRACT Trial: rationale for early intervention for iliofemoral DVT. Perspect Vasc Surg Endovasc Ther 2010; [Epub ahead of print].
40. Vedantham S. Deep venous thrombosis: the opportunity at hand. AJR Am J Roentgenol 2009; 193: 922-927.
41. Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med 2008; 168: 425-430. (Pubitemid 351347134)
42. Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147: 766-774. (Pubitemid 351664441)
43. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-768. (Pubitemid 30165236)
44. Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med 2001; 110: 515-519.
45. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960. (Pubitemid 35440241)
46. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112: 416-422.
47. White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 2000; 160: 2033-2041. (Pubitemid 30437587)
48. Mismetti P, Rivron-Guillot K, Quenet S, Décousus H, Laporte S, Epinat M et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest 2007; 131: 223-229. (Pubitemid 46122997)
49. Legnani C, Mattarozzi S, Cini M, Cosmi B, Favaretto E, Palareti G. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. Br J Haematol 2006; 134: 227-232. (Pubitemid 43893916)
50. Linnemann B, Zgouras D, Schindewolf M, Schwonberg J, Jarosch-Preusche M, Lindhoff-Last E. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Blood Coagul Fibrinolysis 2008; 19: 159-165. (Pubitemid 351252995)
51. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995; 332: 1661-1665.
52. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907. (Pubitemid 29141050)
53. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliáni MR, Miccio M et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139: 19-25.
54. Pini M, Aiello S, Manotti C, Pattacini C, Quintavalla R, Poli T et al. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 1994; 72: 191-197. (Pubitemid 24251278)
55. Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606-611.
56. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160: 769-774. (Pubitemid 30165237)
57. Pinede L, Ninet J, Duhaut P, Chabaud S, DemolombeRague S, Durieu I et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453-2460. (Pubitemid 32493371)
58. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2001; 362: 523-526.
59. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005;293:2352-2361. (Pubitemid 40676757)
60. Garcia-Fuster MJ, Forner MJ, Fernández C, Gil J, Vaya A, Maldonado L. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. PathophysiolHaemost Thromb 2005; 34: 6-12. (Pubitemid 41642799)
61. Kearon C, Julian JA, Kovacs MJ, Anderson DR, Wells P, Mackinnon B et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood 2008; 112: 4432-4436.
62. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-1248. (Pubitemid 34595030)
63. Lukas PS, Krummenacher R, Biasiutti FD, Begré S, Znoj H, von Känel R. Association of fatigue and psychological distress with quality of life in patients with a previous venous thromboembolic event. Thromb Haemost 2009; 102: 1219-1226.
64. Blättler W, Partsch H. Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis. Int Angiol 2003; 22: 393-400. (Pubitemid 38324808)
65. Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009; 145: 286-295.
66. Giannoukas AD, Labropoulos N, Michaels JA. Compression with or without early ambulation in the prevention of post-thrombotic syndrome: a systematic review. Eur J Vasc Endovasc Surg 2006; 32: 217-221. (Pubitemid 44089409)
67. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(Suppl):401S-428S.
68. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl): 454S-545S.
69. van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3: 939-942.
70. Fanikos J, Piazza G, Zayaruzny M, Goldhaber SZ. Long-term complications of medical patients with hospital-acquired venous thromboembolism. Thromb Haemost 2009; 102: 688-693.
71. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497.
72. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. AmJ Med 1997; 103: 11-17.
73. Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med 2009; 150: 577-585.
74. Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-318.
75. Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost 2005; 94: 969-974.
76. Kahn SR, Shbaklo H, Shapiro S, Wells PS, Kovacs MJ, Rodger MA et al. Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovasc Disord 2007; 7:21.